Egalet Corporation is a fully integrated specialty pharmaceutical company headquartered in Pennsylvania focused on developing, manufacturing, and commercializing treatments.
Subscribe to see Egalet Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Egalet Corp is a pharmaceuticals company headquartered in United States. It has raised at least $56.5M across the 2 funding rounds on record. Its most recent funding round raised $42.2M in January 2019. Xcout tracks 5 named people at Egalet Corp, including Robert Radie (President and Chief Executive Officer and Member of our Board of Directors).
At least $56.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $42.2M | — | |
| Series B | $14.3M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Egalet Corp's closest competitors — see the full list of competitors and alternatives →
Egetis Therapeutics is a Swedish specialty pharmaceutical company headquartered in Stockholm that focuses on developing and commercializing treatments for serious rare diseases.
Endo, Inc. is a Pennsylvania-based company incorporated as a Delaware corporation that operates pharmaceutical businesses, including Endo Pharmaceuticals, with executive offices located in Pennsylvania.
AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company based in San Mateo and Redwood City, California, focused on developing and commercializing therapeutic products.
Lannett Company, Inc. is a leading manufacturer of high-quality, affordable generic pharmaceutical products. Headquartered in Trevose, Pennsylvania, it has US-based headquarters and manufacturing facilities and has been operating for over 75 years.
Solaris Pharma Corporation is a specialty pharmaceutical company founded in 2014 and located in Bridgewater, New Jersey.
Founded in 2003, Nexus Pharmaceuticals is a US-based, family-owned, and minority-led pharmaceutical manufacturer that specializes in innovative processes to produce difficult-to-manufacture injectable drugs.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.